The relationship between cyclin G1 and survival in patients treated surgically for HCC

Hepato-Gastroenterology

Volumn 60, Issue 122, 2013, Pages 153-159

  Cui, Xiaopeng ^a   Yu, Litao ^a   Wang, Yingying ^a   He, Song ^a   Zhang, Yixin ^a   Wan, Chunhua ^a   Shi, Jing ^a   Jiang, Wenyang ^a   Zhang, Jing ^a   Mei, Guanglin ^a   Ni, Runzhou ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Cyclin G1; Hepatocellular carcinoma; Serum starvation; Survival

Indexed keywords

CYCLIN G1; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE PROGRESSION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN G1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84877694058     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge1549     Document Type: Article

References (22)

1. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Frautneni JF, Jr.: International trends and patterns of primary liver cancer. Int J Cancer 2001; 94(2):290-296. (Pubitemid 32911426)
2. Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7(3):237-257.
3. Lu M, Fei M, Cheng C, et al.: Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy. Arch Med Res 2008; 39(6):573-581. (Pubitemid 352033609)
4. Horne MC, Goolsby GL, Donaldson KL, et al.: Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem 1996; 271(11):6050-6061. (Pubitemid 26095408)
5. Tamura K, Kanaoka Y, Jinno S, et al.: Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene 1993; 8(8):2113-2118. (Pubitemid 23226944)
6. Okamoto K, Kamibayashi C, Serrano M, et al.: p53-dependent association between cyclin G and the B′ subunit of protein phosphatase 2A. Mol Cell Biol 1996; 16(11):6593-6602. (Pubitemid 26361018)
7. Reimer CL, Borras AM, Kurdistani SK, et al.: Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem 1999; 274(16):11022-11029.
8. Baek WK, Kim D, Jung N, et al.: Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol 2003; 188(3):634-639. (Pubitemid 36332426)
9. Kimura SH, Nojima H: Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein. Genes Cells 2002; 7(8):869-880. (Pubitemid 34947089)
10. Okamoto K, Prives C: A role of cyclin G in the process of apoptosis. Oncogene 1999; 18(32):4606-4615. (Pubitemid 29405892)
11. Zhao L, Samuels T, Winckler S, et al.: Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res 2003; 1(3):195-206. (Pubitemid 36330201)
12. Simonetti RG, Camma C, Fiorello F, et al.: Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36(7):962-972.
13. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ: Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000; 19(54):6297-6305. (Pubitemid 32641843)
14. Alevizos I, Mahadevappa M, Zhang X, et al.: Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001; 20(43):6196-6204. (Pubitemid 32964432)
15. Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT: Cyclin G2 dysregulation in human oral cancer. Cancer Res 2004; 64(24):8980-8986. (Pubitemid 39665507)
16. Liu J, Cui ZS, Luo Y, et al.: Effect of cyclin G2 on proliferative ability of SGC-7901 cell. World J Gastroenterol 2004; 10(9):1357-1360. (Pubitemid 39162448)
17. Zauberman A, Lupo A, Oren M: Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene 1995; 10(12):2361-2366.
18. Okamoto K, Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994; 13(20):4816-4822. (Pubitemid 24319363)
19. Hunter T, Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79(4):573-582. (Pubitemid 24363801)
20. Kanaoka Y, Kimura SH, Okazaki I, Ikeda M, Nojima H: GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain. FEBS Lett 1997; 402(1):73-80. (Pubitemid 27056028)
21. Yue L, Daikoku T, Hou X, et al.: Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: evidence for aberrant regulation with Hoxa-10 deficiency. Endocrinology 2005; 146(5):2424-2433. (Pubitemid 40577530)
22. Skotzko M, Wu L, Anderson WF, Gordon EM, Hall FL: Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res 1995; 55(23):5493-5498.